A ‘Second Breakfast’ for Real-Life Hobbits? New Evidence Calls into Question Past Presumptions About Homo Floresiensis
Homo floresiensis, a tiny ancient hominin, often compared to the hobbits of the Lord of the Rings, engaged in a sort of second breakfast.
Read the full articleYou might also wanna read
Ancient hobbit-like humans may have survived on meat left behind by Komodo dragons
Arguably one of the most curious ancient human relatives is Homo floresiensis, a 3-foot-tall species that lived on the Indonesian island of

Study reveals Homo floresiensis was a scavenger, not a hunter, challenging assumptions about the 'hobbit' species
The extinct human species Homo floresiensis was a scavenger, not a hunter, an analysis of fossil animal bones reveals.
Live Science·7d ago
Study reveals Homo floresiensis was a scavenger, not a hunter, challenging assumptions about the 'hobbit' species
The extinct human species Homo floresiensis was a scavenger, not a hunter, an analysis of fossil animal bones reveals.
livescience.com·7d agoAnthropologist Suggests Homo floresiensis May Have Survived Until Modern Times on Flores Island
Three-foot-tall “ape-men” defied survival expectations. One researcher isn't convinced they’re entirely gone.

Flores Hobbits' eating habits offer clues about their evolutionary past
If Homo floresiensis wasn't a fire-using hunter, its origins could be different than we thought.
Study suggests Homo floresiensis scavenged Komodo dragon leftovers rather than hunting
Homo floresiensis may have scavenged Komodo dragon leftovers instead of hunting small elephant relatives.
Study suggests Homo floresiensis scavenged Komodo dragon leftovers rather than hunting
Homo floresiensis may have scavenged Komodo dragon leftovers instead of hunting small elephant relatives.
Study suggests Homo floresiensis scavenged meat left by Komodo dragons rather than hunting big game
An experiment that involved feeding a dead goat to a Komodo dragon as well as an analysis of thousands of ancient bones suggests that Homo f

Comments
Sign in to join the conversation.
No comments yet. Be the first.